Cargando…
Vaccine-induced immune thrombotic thrombocytopenia
In response to the COVID-19 pandemic, vaccines for SARS-CoV-2 were developed, tested, and introduced at a remarkable speed. Although the vaccine introduction had a major impact on the evolution of COVID-19, some potential rare side-effects of the vaccines were observed. Within a short period, three...
Autores principales: | Klok, Frederikus A, Pai, Menaka, Huisman, Menno V, Makris, Michael |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Ltd.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8585488/ https://www.ncbi.nlm.nih.gov/pubmed/34774202 http://dx.doi.org/10.1016/S2352-3026(21)00306-9 |
Ejemplares similares
-
Vaccine‐induced immune thrombotic thrombocytopenia (VITT): Update on diagnosis and management considering different resources
por: Greinacher, Andreas, et al.
Publicado: (2022) -
Vaccine‐induced immune thrombotic thrombocytopenia presenting with normal platelet count
por: Page, David, et al.
Publicado: (2021) -
Vaccine-induced immune thrombotic thrombocytopenia
por: Kanack, Adam J., et al.
Publicado: (2022) -
Vaccine-induced immune thrombotic thrombocytopenia
por: Cines, Douglas B., et al.
Publicado: (2023) -
Vaccine-induced immune thrombotic thrombocytopenia (VITT)
por: Warkentin, Theodore E.
Publicado: (2022)